Your browser doesn't support javascript.
loading
Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.
Jong, Robyn M; Van Dis, Erik; Berry, Samuel B; Nguyenla, Xammy; Baltodano, Alexander; Pastenkos, Gabrielle; Xu, Chenling; Fox, Douglas; Yosef, Nir; McWhirter, Sarah M; Stanley, Sarah A.
Afiliación
  • Jong RM; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.
  • Van Dis E; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.
  • Berry SB; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.
  • Nguyenla X; Division of Infectious Disease and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA.
  • Baltodano A; Division of Infectious Disease and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA.
  • Pastenkos G; Comparative Pathology Laboratory, University of California, Davis, Davis, CA.
  • Xu C; Center for Computational Biology, University of California, Berkeley, Berkeley, CA.
  • Fox D; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.
  • Yosef N; Center for Computational Biology, University of California, Berkeley, Berkeley, CA.
  • McWhirter SM; Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA.
  • Stanley SA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA; and.
J Immunol ; 208(2): 407-419, 2022 01 15.
Article en En | MEDLINE | ID: mdl-34965963

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Adyuvantes Inmunológicos / Interleucina-17 / Vacunas contra la Tuberculosis / Células Th17 / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Adyuvantes Inmunológicos / Interleucina-17 / Vacunas contra la Tuberculosis / Células Th17 / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá